Tg Therapeutics (TGTX) Selling, General & Administrative (2011 - 2026)
Tg Therapeutics (TGTX) posted Selling, General & Administrative of $82.13 million for Q2 2026, up 47.8% from $55.59 million a year earlier but down 6.9% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Selling, General & Administrative (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Tg Therapeutics was $296.47 million, up 58.7% year-over-year; for FY2025, it was $232.03 million, up 50.4% from FY2024.
- Annual Selling, General & Administrative has increased for three consecutive years, with a five-year compound annual growth rate of 16.6% (FY2020 to FY2025).
- In prior years, Tg Therapeutics' Selling, General & Administrative was $154.3 million in FY2024 (+25.7%), $122.71 million in FY2023 (+28.5%), $95.48 million in FY2022 (-25.5%) and $128.09 million in FY2021 (+18.8%).
- Quarterly Selling, General & Administrative has run from a low of $12.64 million in Q2 2022 to a high of $88.22 million in Q1 2026 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last ten quarters, with growth averaging 47.1% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2023, with growth of 143.0%; the weakest was Q2 2022, with a decline of 62.8%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $88.22 million (Q1 2026), $62.75 million (Q4 2025) and $63.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Tg Therapeutics | 8.31 Bn | 7.70 Bn | 199.14 Mn | 82.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.13 Mn |
| Mar 31, 2026 | 88.22 Mn |
| Dec 31, 2025 | 62.75 Mn |
| Sep 30, 2025 | 63.37 Mn |
| Jun 30, 2025 | 55.59 Mn |
| Mar 31, 2025 | 50.33 Mn |
| Dec 31, 2024 | 38.96 Mn |
| Sep 30, 2024 | 41.97 Mn |
| Jun 30, 2024 | 38.79 Mn |
| Mar 31, 2024 | 34.58 Mn |
| Dec 31, 2023 | 31.15 Mn |
| Sep 30, 2023 | 32.77 Mn |
| Jun 30, 2023 | 30.72 Mn |
| Mar 31, 2023 | 28.07 Mn |
| Dec 31, 2022 | 47.98 Mn |
| Sep 30, 2022 | 14.25 Mn |
| Jun 30, 2022 | 12.64 Mn |
| Mar 31, 2022 | 20.61 Mn |
| Dec 31, 2021 | 32.41 Mn |
| Sep 30, 2021 | 34.90 Mn |
API Access
Tg Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();